In the process of death-receptor-mediated apoptosis, caspase-8 activation is required via cleavage; higher levels of cleaved caspase-8 have been associated with better clinical outcomes of GBM patients, rendering cleaved caspase-8 indicative of GBM prognoses [11,21]. Here, CASP8 is linked to glioblastoma.